Riding China’s Oncology Market: ‘Verticalization’ Best?
Executive Summary
While there have been a number of positive changes in the operating and regulatory environment in China, pharmaceutical companies will still need a focused strategy to succeed in the country’s increasingly competitive but potentially lucrative oncology market, according to one expert.